This O O O O
website O O O O
is O O O O
intended O O O O
for O O O O
U.S. O O O O
residents O O O O
only. O O O O
This O O O O
website O O O O
contains O O O O
information O O O O
about O O O O
products O O O O
that O O O O
may O O O O
not O O O O
be O O O O
available O O O O
in O O O O
all O O O O
countries, O O O O
or O O O O
may O O O O
be O O O O
available O O O O
under O O O O
different O O O O
trademarks, O O O O
for O O O O
different O O O O
indications, O O O O
or O O O O
in O O O O
different O O O O
dosages. O O O O
Nothing O O O O
contained O O O O
herein O O O O
should O O O O
be O O O O
considered O O O O
a O O O O
solicitation, O O O O
promotion O O O O
or O O O O
advertisement O O O O
for O O O O
any O O O O
drug O O O O
including O O O O
those O O O O
under O O O O
development. O O O O
Any O O O O
information O O O O
on O O O O
the O O O O
products O O O O
contained O O O O
herein O O O O
is O O O O
not O O O O
intended O O O O
to O O O O
provide O O O O
medical O O O O
advice O O O O
nor O O O O
should O O O O
be O O O O
used O O O O
as O O O O
a O O O O
substitute O O O O
for O O O O
the O O O O
advice O O O O
provided O O O O
by O O O O
your O O O O
physician O O O O
or O O O O
other O O O O
healthcare O O O O
provider. O O O O
Oncology Reason 4 O O
Astellas Reason 4 O O
is Reason 4 O O
committed Reason 4 O O
to Reason 4 O O
the Reason 4 O O
development Reason 4 O O
of Reason 4 O O
cancer Reason 4 O O
therapeutics Reason 4 O O
that Reason 4 O O
we Reason 4 O O
believe Reason 4 O O
will Reason 4 O O
deliver Reason 4 O O
innovative Reason 4 O O
treatments Reason 4 O O
to Reason 4 O O
cancer Reason 4 O O
patients Reason 4 O O
throughout Reason 4 O O
the Reason 4 O O
world Reason 4 O O
with Reason 4 O O
the Reason 4 O O
potential Reason 4 O O
to Reason 4 O O
have Reason 4 O O
a Reason 4 O O
significant Reason 4 O O
positive Reason 4 O O
impact Reason 4 O O
on Reason 4 O O
their Reason 4 O O
lives. Reason 4 O O
Oncology Reason 4 O O
is Reason 4 O O
the Reason 4 O O
largest Reason 4 O O
therapeutic Reason 4 O O
area Reason 4 O O
within Reason 4 O O
Astellas, Reason 4 O O
accounting Reason 4 O O
for Reason 4 O O
half Reason 4 O O
of Reason 4 O O
the Reason 4 O O
company's Reason 4 O O
Development Reason 4 O O
spend. Reason 4 O O
We Reason 4 O O
are Reason 4 O O
proud Reason 4 O O
of Reason 4 O O
our Reason 4 O O
products Reason 4 O O
Xtandi Reason 4 O O
and Reason 4 O O
Tarceva, Reason 4 O O
which Reason 4 O O
provide Reason 4 O O
important Reason 4 O O
treatment Reason 4 O O
options Reason 4 O O
for Reason 4 O O
patients Reason 4 O O
with Reason 4 O O
metastatic Reason 4 O O
prostate Reason 4 O O
cancer Reason 4 O O
and Reason 4 O O
lung Reason 4 O O
cancer Reason 4 O O
respectively. Reason 4 O O
We Reason 4 O O
acquired Reason 4 O O
rights Reason 4 O O
to Reason 4 O O
these Reason 4 O O
compounds Reason 4 O O
when Reason 4 O O
in Reason 4 O O
development Reason 4 O O
and Reason 4 O O
helped Reason 4 O O
to Reason 4 O O
bring Reason 4 O O
them Reason 4 O O
to Reason 4 O O
the Reason 4 O O
market Reason 4 O O
where Reason 4 O O
they Reason 4 O O
are Reason 4 O O
currently Reason 4 O O
treatments Reason 4 O O
relied Reason 4 O O
upon Reason 4 O O
by Reason 4 O O
patients Reason 4 O O
and Reason 4 O O
their Reason 4 O O
physicians. Reason 4 O O
Astellas Reason 4 O O
Oncology Reason 4 O O
is Reason 4 O O
built Reason 4 O O
on Reason 4 O O
a Reason 4 O O
healthy Reason 4 O O
mix Reason 4 O O
of Reason 4 O O
internal Reason 4 O O
and Reason 4 O O
external Reason 4 O O
innovation. Reason 4 O O
As Reason 4 O O
a Reason 4 O O
global Reason 4 O O
company Reason 4 O O
headquartered Reason 4 O O
in Reason 4 O O
Japan, Reason 4 O O
Astellas Reason 4 O O
has Reason 4 O O
also Reason 4 O O
assisted Reason 4 O O
many Reason 4 O O
partners Reason 4 O O
with Reason 4 O O
the Reason 4 O O
clinical Reason 4 O O
development Reason 4 O O
and Reason 4 O O
commercialization Reason 4 O O
of Reason 4 O O
oncology Reason 4 O O
products Reason 4 O O
in Reason 4 O O
Japan Reason 4 O O
and Reason 4 O O
throughout Reason 4 O O
Asia. Reason 4 O O
To Reason 4 O O
supplement Reason 4 O O
our Reason 4 O O
internal Reason 4 O O
research Reason 4 O O
efforts, Reason 4 O O
which Reason 4 O O
has Reason 4 O O
produced Reason 4 O O
gilteritinib Reason 4 O O
a Reason 4 O O
FLT3/AXL Reason 4 O O
inhibitor Reason 4 O O
now Reason 4 O O
in Reason 4 O O
late Reason 4 O O
stage Reason 4 O O
development Reason 4 O O
for Reason 4 O O
AML, Reason 4 O O
we Reason 4 O O
are Reason 4 O O
actively Reason 4 O O
seeking Reason 4 O O
to Reason 4 O O
partner Reason 4 O O
with Reason 4 O O
academic Reason 4 O O
or Reason 4 O O
industry Reason 4 O O
stakeholders Reason 4 O O
that Reason 4 O O
share Reason 4 O O
our Reason 4 O O
passion Reason 4 O O
for Reason 4 O O
bringing Reason 4 O O
innovative Reason 4 O O
cancer Reason 4 O O
care Reason 4 O O
to Reason 4 O O
patients. Reason 4 O O
In Reason 4 O O
oncology, Reason 4 O O
Astellas Reason 4 O O
has Reason 4 O O
demonstrated Reason 4 O O
a Reason 4 O O
willingness Reason 4 O O
to Reason 4 O O
structure Reason 4 O O
collaborations Reason 4 O O
that Reason 4 O O
meet Reason 4 O O
the Reason 4 O O
needs Reason 4 O O
of Reason 4 O O
our Reason 4 O O
partners Reason 4 O O
and Reason 4 O O
support Reason 4 O O
complimentary Reason 4 O O
scientific Reason 4 O O
contributions Reason 4 O O
to Reason 4 O O
the Reason 4 O O
programs Reason 4 O O
for Reason 4 O O
the Reason 4 O O
benefit Reason 4 O O
of Reason 4 O O
patients Reason 4 O O
globally. Reason 4 O O
These Reason 4 O O
efforts Reason 4 O O
have Reason 4 O O
included Reason 4 O O
providing Reason 4 O O
funding Reason 4 O O
for Reason 4 O O
preclinical Reason 4 O O
and Reason 4 O O
early Reason 4 O O
clinical Reason 4 O O
work Reason 4 O O
conducted Reason 4 O O
by Reason 4 O O
academic Reason 4 O O
collaborators Reason 4 O O
and Reason 4 O O
private Reason 4 O O
companies. Reason 4 O O
We Reason 4 O O
have Reason 4 O O
also Reason 4 O O
completed Reason 4 O O
licensing Reason 4 O O
arrangements Reason 4 O O
to Reason 4 O O
gain Reason 4 O O
access Reason 4 O O
to Reason 4 O O
both Reason 4 O O
technology Reason 4 O O
and Reason 4 O O
compounds Reason 4 O O
in Reason 4 O O
clinical Reason 4 O O
development. Reason 4 O O
We Reason 4 O O
recently Reason 4 O O
acquired Reason 4 O O
a Reason 4 O O
German Reason 4 O O
biotechnology Reason 4 O O
company Reason 4 O O
Ganymed Reason 4 O O
Pharmaceuticals, Reason 4 O O
their Reason 4 O O
desired Reason 4 O O
outcome, Reason 4 O O
gaining Reason 4 O O
the Reason 4 O O
rights Reason 4 O O
to Reason 4 O O
an Reason 4 O O
antibody Reason 4 O O
that Reason 4 O O
has Reason 4 O O
demonstrated Reason 4 O O
significant Reason 4 O O
potential Reason 4 O O
in Reason 4 O O
Phase Reason 4 O O
2 Reason 4 O O
studies Reason 4 O O
and Reason 4 O O
has Reason 4 O O
generated Reason 4 O O
data Reason 4 O O
in Reason 4 O O
gastroesophageal Reason 4 O O
cancer Reason 4 O O
and Reason 4 O O
programs Reason 4 O O
related Reason 4 O O
to Reason 4 O O
claudin Reason 4 O O
biology. Reason 4 O O
Our Reason 4 O O
collaboration Reason 4 O O
with Reason 4 O O
Potenza Reason 4 O O
is Reason 4 O O
helping Reason 4 O O
propel Reason 4 O O
Astellas Reason 4 O O
forward Reason 4 O O
in Reason 4 O O
immmuno-oncology Reason 4 O O
(IO) Reason 4 O O
and Reason 4 O O
we Reason 4 O O
believe Reason 4 O O
this Reason 4 O O
will Reason 4 O O
produce Reason 4 O O
a Reason 4 O O
series Reason 4 O O
of Reason 4 O O
novel Reason 4 O O
antibodies Reason 4 O O
that Reason 4 O O
are Reason 4 O O
at Reason 4 O O
the Reason 4 O O
forefront Reason 4 O O
of Reason 4 O O
innovation Reason 4 O O
and Reason 4 O O
represent Reason 4 O O
the Reason 4 O O
next Reason 4 O O
wave Reason 4 O O
of Reason 4 O O
novel Reason 4 O O
targets. Reason 4 O O
Areas Reason 4 O O
of Reason 4 O O
Interest: Reason 4 O O
- Reason 4 O O
Genitourinary Reason 4 O O
Malignancy Reason 4 O O
treated Reason 4 O O
by Reason 4 O O
either Reason 4 O O
urologists Reason 4 O O
or Reason 4 O O
medical Reason 4 O O
oncologists Reason 4 O O
- Reason 4 O O
Hematologic Reason 4 O O
Oncology, Reason 4 O O
especially Reason 4 O O
products Reason 4 O O
with Reason 4 O O
the Reason 4 O O
potential Reason 4 O O
to Reason 4 O O
ultimately Reason 4 O O
be Reason 4 O O
prescribed Reason 4 O O
by Reason 4 O O
the Reason 4 O O
hematologists Reason 4 O O
treating Reason 4 O O
AML Reason 4 O O
- Reason 4 O O
Immuno-oncology Reason 4 O O
approaches Reason 4 O O
that Reason 4 O O
would Reason 4 O O
supplement Reason 4 O O
our Reason 4 O O
growing Reason 4 O O
pipeline Reason 4 O O
- Reason 4 O O
Agents Reason 4 O O
with Reason 4 O O
demonstrated Reason 4 O O
clinical Reason 4 O O
activity Reason 4 O O
based Reason 4 O O
on Reason 4 O O
innovative Reason 4 O O
approaches Reason 4 O O
- Reason 4 O O
Core Reason 4 O O
research Reason 4 O O
technologies Reason 4 O O
that Reason 4 O O
would Reason 4 O O
expand Reason 4 O O
our Reason 4 O O
capabilities Reason 4 O O
Urology Reason 4 O O
Functional Reason 4 O O
urological Reason 4 O O
problems Reason 4 O O
continue Reason 4 O O
to Reason 4 O O
have Reason 4 O O
widespread Reason 4 O O
impact Reason 4 O O
for Reason 4 O O
both Reason 4 O O
men Reason 4 O O
and Reason 4 O O
women. Reason 4 O O
The Reason 4 O O
introduction Reason 4 O O
of Reason 4 O O
mirabegron Reason 4 O O
(3 Reason 4 O O
adrenergic Reason 4 O O
receptor Reason 4 O O
agonist) Reason 4 O O
has Reason 4 O O
added Reason 4 O O
to Reason 4 O O
the Reason 4 O O
armamentarium Reason 4 O O
and Reason 4 O O
to Reason 4 O O
the Reason 4 O O
historically Reason 4 O O
strong Reason 4 O O
presence Reason 4 O O
of Reason 4 O O
Astellas Reason 4 O O
in Reason 4 O O
the Reason 4 O O
urology Reason 4 O O
therapeutic Reason 4 O O
area. Reason 4 O O
However, Reason 4 O O
functional Reason 4 O O
bladder Reason 4 O O
problems Reason 4 O O
continue Reason 4 O O
to Reason 4 O O
be Reason 4 O O
an Reason 4 O O
issue Reason 4 O O
with Reason 4 O O
patients Reason 4 O O
worldwide, Reason 4 O O
and Reason 4 O O
sometimes Reason 4 O O
have Reason 4 O O
more Reason 4 O O
severe Reason 4 O O
consequences. Reason 4 O O
Astellas Reason 4 O O
is Reason 4 O O
active Reason 4 O O
in Reason 4 O O
functional Reason 4 O O
urology Reason 4 O O
with Reason 4 O O
tamsulosin Reason 4 O O
for Reason 4 O O
LUTS Reason 4 O O
BPH, Reason 4 O O
solifenacin Reason 4 O O
and Reason 4 O O
mirabegron Reason 4 O O
for Reason 4 O O
overactive Reason 4 O O
bladder, Reason 4 O O
and Reason 4 O O
active Reason 4 O O
development Reason 4 O O
programs Reason 4 O O
in Reason 4 O O
all Reason 4 O O
the Reason 4 O O
areas Reason 4 O O
of Reason 4 O O
interest Reason 4 O O
named Reason 4 O O
below. Reason 4 O O
A Reason 4 O O
new Reason 4 O O
program, Reason 4 O O
fezolinetant Reason 4 O O
in Reason 4 O O
menopause Reason 4 O O
related Reason 4 O O
vasomotor Reason 4 O O
symptoms Reason 4 O O
using Reason 4 O O
an Reason 4 O O
NK3 Reason 4 O O
antagonist Reason 4 O O
(non-hormonal Reason 4 O O
MoA), Reason 4 O O
has Reason 4 O O
recently Reason 4 O O
been Reason 4 O O
added Reason 4 O O
to Reason 4 O O
our Reason 4 O O
pipeline Reason 4 O O
through Reason 4 O O
the Reason 4 O O
acquisition Reason 4 O O
of Reason 4 O O
Belgian Reason 4 O O
biotechnology Reason 4 O O
company Reason 4 O O
Ogeda. Reason 4 O O
Fezolinetant Reason 4 O O
complements Reason 4 O O
the Reason 4 O O
more Reason 4 O O
traditional Reason 4 O O
development Reason 4 O O
programs Reason 4 O O
and Reason 4 O O
our Reason 4 O O
development Reason 4 O O
experience Reason 4 O O
and Reason 4 O O
tackles Reason 4 O O
a Reason 4 O O
critical Reason 4 O O
unmet Reason 4 O O
medical Reason 4 O O
need Reason 4 O O
for Reason 4 O O
patients. Reason 4 O O
With Reason 4 O O
its Reason 4 O O
experience Reason 4 O O
in Reason 4 O O
the Reason 4 O O
area Reason 4 O O
Astellas Reason 4 O O
continues Reason 4 O O
to Reason 4 O O
have Reason 4 O O
an Reason 4 O O
active Reason 4 O O
search Reason 4 O O
program Reason 4 O O
for Reason 4 O O
development Reason 4 O O
opportunities Reason 4 O O
with Reason 4 O O
innovative Reason 4 O O
mechanisms Reason 4 O O
relating Reason 4 O O
to Reason 4 O O
the Reason 4 O O
areas Reason 4 O O
of Reason 4 O O
interest. Reason 4 O O
Programs Reason 4 O O
with Reason 4 O O
human Reason 4 O O
data Reason 4 O O
are Reason 4 O O
of Reason 4 O O
greatest Reason 4 O O
interest. Reason 4 O O
Areas O O O O
of O O O O
Interest: O O O O
- O O O O
Underactive O O O O
Bladder O O O O
- O O O O
Nocturia O O O O
- O O O O
Interstitial O O O O
cystitis/bladder O O O O
pain O O O O
syndrome O O O O
Nephrology O O O O
There O O O O
is O O O O
a O O O O
growing O O O O
prevalence O O O O
of O O O O
type O O O O
2 O O O O
diabetes O O O O
mellitus O O O O
and O O O O
a O O O O
consequential O O O O
rise O O O O
in O O O O
diabetic O O O O
kidney O O O O
disease O O O O
(DKD). O O O O
Despite O O O O
the O O O O
current O O O O
standard O O O O
of O O O O
care O O O O
of O O O O
ACE O O O O
inhibitors O O O O
or O O O O
angiotensin O O O O
receptor O O O O
blockers, O O O O
there O O O O
remains O O O O
a O O O O
high O O O O
medical O O O O
need O O O O
to O O O O
slow O O O O
the O O O O
progression O O O O
of O O O O
diabetic O O O O
kidney O O O O
disease O O O O
and O O O O
prevent O O O O
or O O O O
delay O O O O
the O O O O
need O O O O
for O O O O
dialysis. O O O O
Increasing O O O O
recognition O O O O
of O O O O
acute O O O O
kidney O O O O
injury O O O O
(AKI) O O O O
and O O O O
its O O O O
short O O O O
and O O O O
longer O O O O
term O O O O
medical O O O O
consequences O O O O
also O O O O
provides O O O O
an O O O O
opportunity O O O O
to O O O O
intervene O O O O
in O O O O
this O O O O
area. O O O O
Astellas O O O O
is O O O O
active O O O O
in O O O O
nephrology O O O O
with O O O O
bixalomer O O O O
for O O O O
hyperphosphatemia O O O O
on O O O O
the O O O O
market O O O O
in O O O O
Japan O O O O
(in-licensed O O O O
from O O O O
Ilypsa, O O O O
now O O O O
Amgen), O O O O
calcium O O O O
polystyrene O O O O
sulfonate O O O O
for O O O O
hyperkalemia O O O O
in O O O O
Japan O O O O
(partnership O O O O
with O O O O
Sanwa O O O O
Kagaku O O O O
Kenkyusho), O O O O
roxadustat O O O O
in O O O O
phase O O O O
3 O O O O
development O O O O
for O O O O
the O O O O
anaemia O O O O
of O O O O
chronic O O O O
kidney O O O O
disease O O O O
in O O O O
Europe O O O O
and O O O O
Japan O O O O
(partnership O O O O
with O O O O
FibroGen) O O O O
and O O O O
earlier O O O O
phase O O O O
global O O O O
projects O O O O
in O O O O
DKD O O O O
and O O O O
AKI. O O O O
We O O O O
are O O O O
also O O O O
interested O O O O
in O O O O
acquiring O O O O
rights O O O O
to O O O O
projects O O O O
in O O O O
AKI O O O O
with O O O O
a O O O O
focus O O O O
on O O O O
Phase O O O O
II O O O O
assets. O O O O
Other O O O O
nephrology O O O O
indications O O O O
could O O O O
also O O O O
be O O O O
of O O O O
interest, O O O O
especially O O O O
if O O O O
providing O O O O
synergy O O O O
with O O O O
our O O O O
primary O O O O
areas O O O O
of O O O O
interest. O O O O
Areas Reason 4 O O
of Reason 4 O O
Interest: Reason 4 O O
- Reason 4 O O
Acute Reason 4 O O
Kidney Reason 4 O O
Injury Reason 4 O O
Immunology Reason 4 O O
Areas Reason 4 O O
of Reason 4 O O
Interest: Reason 4 O O
- Reason 4 O O
Systemic Reason 4 O O
Lupus Reason 4 O O
erythematosus Reason 4 O O
- Reason 4 O O
Systemic Reason 4 O O
sclerosis Reason 4 O O
- Reason 4 O O
Celiac Reason 4 O O
disease Reason 4 O O
- Reason 4 O O
Allergies Reason 4 O O
Neuroscience Reason 4 O O
Astellas Reason 4 O O
has Reason 4 O O
identified Reason 4 O O
neuroscience Reason 4 O O
as Reason 4 O O
a Reason 4 O O
focused Reason 4 O O
area Reason 4 O O
for Reason 4 O O
research Reason 4 O O
and Reason 4 O O
development Reason 4 O O
due Reason 4 O O
to Reason 4 O O
the Reason 4 O O
high Reason 4 O O
unmet Reason 4 O O
medical Reason 4 O O
needs Reason 4 O O
and Reason 4 O O
tremendous Reason 4 O O
research Reason 4 O O
potential. Reason 4 O O
Our Reason 4 O O
efforts Reason 4 O O
in Reason 4 O O
neuroscience Reason 4 O O
include Reason 4 O O
both Reason 4 O O
central Reason 4 O O
nervous Reason 4 O O
system Reason 4 O O
(CNS) Reason 4 O O
disorders Reason 4 O O
and Reason 4 O O
pain O O O O
therapeutics. O O O O
For O O O O
CNS O O O O
disorders, O O O O
our O O O O
focus O O O O
is O O O O
treatments O O O O
of O O O O
psychiatric O O O O
disorders, O O O O
particularly O O O O
schizophrenia O O O O
and O O O O
bipolar O O O O
disorder. O O O O
These O O O O
diseases O O O O
significantly O O O O
impact O O O O
the O O O O
lives O O O O
of O O O O
millions O O O O
of O O O O
patients O O O O
and O O O O
their O O O O
families O O O O
across O O O O
the O O O O
globe. O O O O
Astellas O O O O
aspires O O O O
to O O O O
understand O O O O
the O O O O
cause O O O O
of O O O O
psychiatric O O O O
disorder O O O O
and O O O O
is O O O O
exploring O O O O
ways O O O O
to O O O O
treat O O O O
all O O O O
aspects O O O O
of O O O O
the O O O O
disease. O O O O
To O O O O
achieve O O O O
this, O O O O
we O O O O
are O O O O
studying O O O O
genetics O O O O
and O O O O
pathophysiology O O O O
of O O O O
the O O O O
diseases O O O O
in-house O O O O
and O O O O
through O O O O
research O O O O
collaborations O O O O
with O O O O
academic O O O O
institutions O O O O
such O O O O
as O O O O
the O O O O
Lieber O O O O
Institute O O O O
for O O O O
Brain O O O O
Development O O O O
(LIBD). O O O O
We O O O O
believe O O O O
that O O O O
this O O O O
approach O O O O
could O O O O
ultimately O O O O
lead O O O O
to O O O O
novel O O O O
targets O O O O
and O O O O
treatments. O O O O
We Reason 4 O O
are Reason 4 O O
looking Reason 4 O O
for Reason 4 O O
a Reason 4 O O
partner Reason 4 O O
who Reason 4 O O
has Reason 4 O O
Phase Reason 4 O O
II Reason 4 O O
or Reason 4 O O
later Reason 4 O O
stage Reason 4 O O
of Reason 4 O O
compounds Reason 4 O O
for Reason 4 O O
treatment Reason 4 O O
of Reason 4 O O
psychiatric Reason 4 O O
conditions. Reason 4 O O
Earlier Reason 4 O O
stage Reason 4 O O
opportunities Reason 4 O O
would Reason 4 O O
also Reason 4 O O
be Reason 4 O O
within Reason 4 O O
our Reason 4 O O
interest, Reason 4 O O
but Reason 4 O O
need Reason 4 O O
to Reason 4 O O
be Reason 4 O O
based Reason 4 O O
on Reason 4 O O
genetics/pathophysiology Reason 4 O O
of Reason 4 O O
the Reason 4 O O
disease. Reason 4 O O
Any Reason 4 O O
kind Reason 4 O O
of Reason 4 O O
modalities Reason 4 O O
are Reason 4 O O
within Reason 4 O O
our Reason 4 O O
scope. Reason 4 O O
Areas O O O O
of O O O O
Interest: O O O O
- O O O O
Treatments O O O O
that O O O O
(1) O O O O
target O O O O
cognitive O O O O
impairment O O O O
associated O O O O
with O O O O
schizophrenia O O O O
and O O O O
cognitive O O O O
impairment O O O O
associated O O O O
with O O O O
psychotic O O O O
bipolar O O O O
disorder, O O O O
(2) O O O O
prevent O O O O
or O O O O
attenuate O O O O
the O O O O
emergence O O O O
of O O O O
schizophrenia O O O O
or O O O O
psychotic O O O O
bipolar O O O O
disorders, O O O O
(3) O O O O
treatments O O O O
for O O O O
Negative O O O O
Symptoms O O O O
in O O O O
Schizophrenia O O O O
- O O O O
Genetics- O O O O
and O O O O
pathophysiology-based O O O O
novel O O O O
therapies O O O O
Muscle O O O O
Diseases O O O O
Skeletal O O O O
muscle O O O O
is O O O O
the O O O O
largest O O O O
tissue O O O O
in O O O O
human O O O O
body. O O O O
Impairment O O O O
of O O O O
certain O O O O
muscle O O O O
functions, O O O O
in O O O O
particular O O O O
conditions O O O O
which O O O O
lead O O O O
muscle O O O O
atrophy, O O O O
can O O O O
cause O O O O
significant O O O O
disabilities O O O O
for O O O O
patients O O O O
in O O O O
activities O O O O
of O O O O
daily O O O O
living. O O O O
Age-related O O O O
loss O O O O
of O O O O
muscle O O O O
mass O O O O
and O O O O
strength O O O O
[sarcopenia], O O O O
several O O O O
cachexic O O O O
conditions O O O O
and O O O O
various O O O O
multiple O O O O
disuse O O O O
muscle O O O O
conditions O O O O
are O O O O
all O O O O
responsible O O O O
for O O O O
the O O O O
inducement O O O O
of O O O O
muscle O O O O
atrophy. O O O O
Astellas' O O O O
drug O O O O
discovery O O O O
team O O O O
sees O O O O
high O O O O
unmet O O O O
medical O O O O
needs O O O O
in O O O O
these O O O O
conditions, O O O O
and O O O O
is O O O O
making O O O O
efforts O O O O
to O O O O
address O O O O
these O O O O
needs O O O O
through O O O O
a O O O O
comprehensive O O O O
therapeutic O O O O
approach. O O O O
In O O O O
addition, O O O O
patients O O O O
who O O O O
present O O O O
with O O O O
neuromuscular O O O O
diseases O O O O
such O O O O
as O O O O
amyotrophic O O O O
lateral O O O O
sclerosis O O O O
[ALS] O O O O
and O O O O
spinal O O O O
muscular O O O O
atrophy O O O O
[SMA] O O O O
show O O O O
a O O O O
dramatic O O O O
decrease O O O O
in O O O O
both O O O O
muscle O O O O
mass O O O O
and O O O O
power O O O O
generation. O O O O
This O O O O
decrease O O O O
in O O O O
mass O O O O
and O O O O
power O O O O
is O O O O
the O O O O
output O O O O
of O O O O
severely O O O O
damaged O O O O
neuronal O O O O
input O O O O
- O O O O
a O O O O
prime O O O O
function O O O O
of O O O O
the O O O O
control O O O O
of O O O O
muscle O O O O
movement. O O O O
To O O O O
address O O O O
the O O O O
high O O O O
unmet O O O O
needs O O O O
of O O O O
patients O O O O
and O O O O
medical O O O O
experts O O O O
in O O O O
the O O O O
above O O O O
mentioned O O O O
muscle O O O O
diseases O O O O
and O O O O
conditions, O O O O
Astellas O O O O
is O O O O
very O O O O
active O O O O
in O O O O
its O O O O
drug O O O O
discovery O O O O
programs, O O O O
utilizing O O O O
proprietary O O O O
research O O O O
technologies O O O O
as O O O O
well O O O O
as O O O O
in O O O O
partnership O O O O
with O O O O
biotechnology O O O O
companies, O O O O
such O O O O
as O O O O
Cytokinetics O O O O
and O O O O
Mitobridge. O O O O
seeking O O O O
potential O O O O
external O O O O
assets O O O O
and O O O O
opportunities. O O O O
Also, O O O O
Astellas O O O O
is O O O O
actively O O O O
seeking O O O O
new O O O O
collaboration Reason 4 O O
opportunities, Reason 4 O O
such Reason 4 O O
as Reason 4 O O
partners Reason 4 O O
who Reason 4 O O
possess Reason 4 O O
assets Reason 4 O O
in Reason 4 O O
clinical Reason 4 O O
stage Reason 4 O O
phase Reason 4 O O
1 Reason 4 O O
or Reason 4 O O
later. Reason 4 O O
Ideal Reason 4 O O
compounds Reason 4 O O
within Reason 4 O O
antibody Reason 4 O O
/ Reason 4 O O
gene Reason 4 O O
therapy Reason 4 O O
/ Reason 4 O O
cell Reason 4 O O
therapy Reason 4 O O
modalities Reason 4 O O
would Reason 4 O O
be Reason 4 O O
of Reason 4 O O
interest. Reason 4 O O
Assets O O O O
in O O O O
preclinical O O O O
stage O O O O
are O O O O
also O O O O
of O O O O
interest O O O O
to O O O O
Astellas O O O O
- O O O O
however O O O O
in O O O O
such O O O O
circumstances, O O O O
assets O O O O
would O O O O
need O O O O
to O O O O
be O O O O
based O O O O
within O O O O
the O O O O
cutting-edge O O O O
/ O O O O
emerging O O O O
science O O O O
paradigm. O O O O
Astellas O O O O
also O O O O
has O O O O
a O O O O
significant O O O O
interest O O O O
in O O O O
the O O O O
synergistic O O O O
field O O O O
of O O O O
novel O O O O
drug O O O O
delivery O O O O
and O O O O
technology O O O O
in O O O O
order O O O O
to O O O O
achieve O O O O
efficient O O O O
drug O O O O
delivery O O O O
into O O O O
muscle O O O O
tissue. O O O O
Areas Reason 4 O O
of Reason 4 O O
Interest: Reason 4 O O
- Reason 4 O O
Novel Reason 4 O O
therapies Reason 4 O O
including Reason 4 O O
gene/cell Reason 4 O O
therapies Reason 4 O O
in Reason 4 O O
neuromuscular Reason 4 O O
diseases Reason 4 O O
- Reason 4 O O
Improvement Reason 4 O O
of Reason 4 O O
muscle Reason 4 O O
functions Reason 4 O O
in Reason 4 O O
non-neuromuscular Reason 4 O O
diseases Reason 4 O O
with Reason 4 O O
aging, Reason 4 O O
cachexia, Reason 4 O O
disuse Reason 4 O O
conditions, Reason 4 O O
chronic Reason 4 O O
organ Reason 4 O O
diseases Reason 4 O O
major Reason 4 O O
surgery Reason 4 O O
and Reason 4 O O
intensive Reason 4 O O
care. Reason 4 O O
- Reason 4 O O
Drug Reason 4 O O
delivery Reason 4 O O
technologies Reason 4 O O
which Reason 4 O O
enable Reason 4 O O
muscle-directed Reason 4 O O
delivery Reason 4 O O
Ophthalmology Reason 4 O O
Eyesight Reason 4 O O
is Reason 4 O O
the Reason 4 O O
important Reason 4 O O
sensory Reason 4 O O
function. Reason 4 O O
Loss Reason 4 O O
of Reason 4 O O
vision Reason 4 O O
leads Reason 4 O O
to Reason 4 O O
significant Reason 4 O O
degradation Reason 4 O O
of Reason 4 O O
quality Reason 4 O O
of Reason 4 O O
life. Reason 4 O O
Ophthalmology Reason 4 O O
area Reason 4 O O
is Reason 4 O O
the Reason 4 O O
place Reason 4 O O
to Reason 4 O O
realize Reason 4 O O
a Reason 4 O O
variety Reason 4 O O
of Reason 4 O O
new Reason 4 O O
therapeutic Reason 4 O O
methods Reason 4 O O
and Reason 4 O O
diagnostic Reason 4 O O
techniques. Reason 4 O O
New Reason 4 O O
modalities Reason 4 O O
such Reason 4 O O
as Reason 4 O O
cell Reason 4 O O
therapy Reason 4 O O
and Reason 4 O O
gene Reason 4 O O
therapy Reason 4 O O
and Reason 4 O O
groundbreaking Reason 4 O O
imaging Reason 4 O O
technologies Reason 4 O O
to Reason 4 O O
non- Reason 4 O O
invasively Reason 4 O O
observe Reason 4 O O
retina Reason 4 O O
are Reason 4 O O
being Reason 4 O O
actively Reason 4 O O
tested. Reason 4 O O
Astellas Reason 4 O O
has Reason 4 O O
focused Reason 4 O O
its Reason 4 O O
attention Reason 4 O O
on Reason 4 O O
this Reason 4 O O
therapeutic Reason 4 O O
area, Reason 4 O O
with Reason 4 O O
cell Reason 4 O O
therapy Reason 4 O O
programs, Reason 4 O O
through Reason 4 O O
its Reason 4 O O
acquisition Reason 4 O O
of Reason 4 O O
Ocata Reason 4 O O
Therapeutics Reason 4 O O
in Reason 4 O O
2015. Reason 4 O O
We Reason 4 O O
also Reason 4 O O
have Reason 4 O O
established Reason 4 O O
a Reason 4 O O
new Reason 4 O O
partnership Reason 4 O O
with Reason 4 O O
CLINO Reason 4 O O
Corporation Reason 4 O O
in Reason 4 O O
the Reason 4 O O
field Reason 4 O O
of Reason 4 O O
gene Reason 4 O O
therapy Reason 4 O O
in Reason 4 O O
2016. Reason 4 O O
To Reason 4 O O
address Reason 4 O O
the Reason 4 O O
unmet Reason 4 O O
medical Reason 4 O O
needs Reason 4 O O
of Reason 4 O O
patients Reason 4 O O
with Reason 4 O O
vision Reason 4 O O
issues, Reason 4 O O
Astellas Reason 4 O O
is Reason 4 O O
now Reason 4 O O
playing Reason 4 O O
an Reason 4 O O
active Reason 4 O O
role Reason 4 O O
in Reason 4 O O
the Reason 4 O O
development Reason 4 O O
of Reason 4 O O
innovative Reason 4 O O
treatment Reason 4 O O
avenues Reason 4 O O
for Reason 4 O O
eye Reason 4 O O
diseases Reason 4 O O
in Reason 4 O O
collaboration Reason 4 O O
with Reason 4 O O
researchers, Reason 4 O O
physicians Reason 4 O O
and Reason 4 O O
all Reason 4 O O
the Reason 4 O O
people Reason 4 O O
with Reason 4 O O
the Reason 4 O O
common Reason 4 O O
spirit. Reason 4 O O
We Reason 4 O O
are Reason 4 O O
currently Reason 4 O O
looking Reason 4 O O
for Reason 4 O O
the Reason 4 O O
opportunities Reason 4 O O
mainly Reason 4 O O
for Reason 4 O O
the Reason 4 O O
back Reason 4 O O
of Reason 4 O O
the Reason 4 O O
eye Reason 4 O O
diseases. Reason 4 O O
As Reason 4 O O
for Reason 4 O O
wet-type Reason 4 O O
age- Reason 4 O O
related Reason 4 O O
macular Reason 4 O O
degeneration Reason 4 O O
(AMD) Reason 4 O O
and Reason 4 O O
diabetic Reason 4 O O
macular Reason 4 O O
edema, Reason 4 O O
we Reason 4 O O
are Reason 4 O O
interested Reason 4 O O
in Reason 4 O O
opportunities Reason 4 O O
which Reason 4 O O
can Reason 4 O O
assert Reason 4 O O
clear Reason 4 O O
advantages Reason 4 O O
over Reason 4 O O
the Reason 4 O O
current Reason 4 O O
standard Reason 4 O O
of Reason 4 O O
care. Reason 4 O O
Regarding Reason 4 O O
dry-type Reason 4 O O
AMD, Reason 4 O O
any Reason 4 O O
type Reason 4 O O
of Reason 4 O O
partnership Reason 4 O O
are Reason 4 O O
welcome Reason 4 O O
including Reason 4 O O
research Reason 4 O O
collaboration Reason 4 O O
looking Reason 4 O O
at Reason 4 O O
the Reason 4 O O
situation Reason 4 O O
that Reason 4 O O
its Reason 4 O O
pathophysiology Reason 4 O O
is Reason 4 O O
less Reason 4 O O
well Reason 4 O O
understood. Reason 4 O O
To Reason 4 O O
treat Reason 4 O O
inherited Reason 4 O O
retinal Reason 4 O O
diseases, Reason 4 O O
our Reason 4 O O
favorite Reason 4 O O
partnership Reason 4 O O
is Reason 4 O O
to Reason 4 O O
seek Reason 4 O O
approach Reason 4 O O
to Reason 4 O O
treat Reason 4 O O
patients Reason 4 O O
in Reason 4 O O
a Reason 4 O O
mutation Reason 4 O O
type Reason 4 O O
independent Reason 4 O O
manner. Reason 4 O O
We Reason 4 O O
are Reason 4 O O
also Reason 4 O O
exploring Reason 4 O O
next-generation Reason 4 O O
therapy Reason 4 O O
for Reason 4 O O
glaucoma/glaucomatic Reason 4 O O
optic Reason 4 O O
neuropathy, Reason 4 O O
which Reason 4 O O
can Reason 4 O O
bring Reason 4 O O
the Reason 4 O O
recovery Reason 4 O O
of Reason 4 O O
visual Reason 4 O O
field. Reason 4 O O
Any Reason 4 O O
kinds Reason 4 O O
of Reason 4 O O
modalities Reason 4 O O
and Reason 4 O O
any Reason 4 O O
types Reason 4 O O
of Reason 4 O O
other Reason 4 O O
retinal Reason 4 O O
diseases Reason 4 O O
are Reason 4 O O
within Reason 4 O O
our Reason 4 O O
scope. Reason 4 O O
Areas O O O O
of O O O O
Interest: O O O O
- O O O O
Back O O O O
of O O O O
the O O O O
eye O O O O
diseases O O O O
(AMD, O O O O
DME, O O O O
inherited O O O O
retinal O O O O
diseases, O O O O
glaucomatic O O O O
optic O O O O
neuropathy....) O O O O
- O O O O
New O O O O
modalities O O O O
including O O O O
cell O O O O
therapy O O O O
and O O O O
gene O O O O
therapy. O O O O
Regenerative O O O O
Medicine O O O O
Areas O O O O
of O O O O
Interest: O O O O
- O O O O
PSC-derived O O O O
cell O O O O
products O O O O
for O O O O
patients O O O O
with O O O O
high O O O O
unmet O O O O
needs O O O O
- O O O O
Technology O O O O
to O O O O
manufacture O O O O
cell O O O O
products O O O O
safe O O O O
and O O O O
efficiently O O O O
Vaccine O O O O
Astellas O O O O
is O O O O
looking O O O O
for O O O O
innovative O O O O
vaccine O O O O
opportunities O O O O
to O O O O
meet O O O O
unmet O O O O
medical O O O O
needs. O O O O
Although O O O O
clinical O O O O
stage O O O O
programs O O O O
are O O O O
preferable, O O O O
earlier O O O O
stage O O O O
opportunities O O O O
including O O O O
research O O O O
collaboration O O O O
are O O O O
also O O O O
within O O O O
our O O O O
scope. O O O O
We O O O O
are O O O O
interested O O O O
in O O O O
vaccines O O O O
against O O O O
pathogens O O O O
including O O O O
bacteria, O O O O
viruses O O O O
and O O O O
fungi O O O O
for O O O O
prophylactic O O O O
and O O O O
therapeutic O O O O
use. O O O O
Areas Reason 4 O O
of Reason 4 O O
Interest: Reason 4 O O
- Reason 4 O O
Healthcare Reason 4 O O
Associated Reason 4 O O
Infection Reason 4 O O
(HAI) Reason 4 O O
vaccines Reason 4 O O
(Gram Reason 4 O O
negative Reason 4 O O
bacteria Reason 4 O O
and Reason 4 O O
others) Reason 4 O O
- Reason 4 O O
Vaccines Reason 4 O O
against Reason 4 O O
virus Reason 4 O O
infections Reason 4 O O
(RSV, Reason 4 O O
CMV, Reason 4 O O
Norovirus Reason 4 O O
and Reason 4 O O
others) Reason 4 O O
- Reason 4 O O
Vaccines Reason 4 O O
for Reason 4 O O
refractory Reason 4 O O
infection Reason 4 O O
Close Reason 4 O O
Gene Reason 4 O O
therapy Reason 4 O O
Gene Reason 4 O O
therapy Reason 4 O O
is Reason 4 O O
an Reason 4 O O
approach Reason 4 O O
to Reason 4 O O
treating Reason 4 O O
disease Reason 4 O O
by Reason 4 O O
either Reason 4 O O
modifying Reason 4 O O
the Reason 4 O O
expression Reason 4 O O
of Reason 4 O O
a Reason 4 O O
gene Reason 4 O O
or Reason 4 O O
the Reason 4 O O
correcting Reason 4 O O
of Reason 4 O O
a Reason 4 O O
mutated Reason 4 O O
gene. Reason 4 O O
The Reason 4 O O
nucleic Reason 4 O O
acid Reason 4 O O
molecule Reason 4 O O
is Reason 4 O O
packaged Reason 4 O O
within Reason 4 O O
a Reason 4 O O
"vector", Reason 4 O O
such Reason 4 O O
as Reason 4 O O
a Reason 4 O O
virus, Reason 4 O O
which Reason 4 O O
is Reason 4 O O
used Reason 4 O O
to Reason 4 O O
deliver Reason 4 O O
the Reason 4 O O
molecule Reason 4 O O
inside Reason 4 O O
the Reason 4 O O
cell Reason 4 O O
to Reason 4 O O
expressed Reason 4 O O
new Reason 4 O O
gene Reason 4 O O
for Reason 4 O O
a Reason 4 O O
functional Reason 4 O O
protein Reason 4 O O
to Reason 4 O O
treat Reason 4 O O
the Reason 4 O O
disease. Reason 4 O O
Many Reason 4 O O
different Reason 4 O O
diseases Reason 4 O O
like Reason 4 O O
number Reason 4 O O
of Reason 4 O O
cancers Reason 4 O O
and Reason 4 O O
monogenic Reason 4 O O
inherited Reason 4 O O
diseases Reason 4 O O
are Reason 4 O O
currently Reason 4 O O
being Reason 4 O O
investigated Reason 4 O O
as Reason 4 O O
candidates Reason 4 O O
for Reason 4 O O
gene Reason 4 O O
therapy. Reason 4 O O
Astellas Reason 4 O O
has Reason 4 O O
several Reason 4 O O
gene Reason 4 O O
therapy Reason 4 O O
programs Reason 4 O O
in Reason 4 O O
pre-clinical Reason 4 O O
R&D Reason 4 O O
pipeline. Reason 4 O O
Adeno-associated Reason 4 O O
Virus-modified Reason 4 O O
Volvox Reason 4 O O
channelrhodopsin-1 Reason 4 O O
CLINO Reason 4 O O
Corporation, Reason 4 O O
to Reason 4 O O
treat Reason 4 O O
retinitis Reason 4 O O
pigmentosa Reason 4 O O
is Reason 4 O O
one Reason 4 O O
of Reason 4 O O
advancing Reason 4 O O
program Reason 4 O O
to Reason 4 O O
provide Reason 4 O O
right Reason 4 O O
to Reason 4 O O
patients. Reason 4 O O
Astellas Reason 4 O O
is Reason 4 O O
pursuing Reason 4 O O
this Reason 4 O O
emerging Reason 4 O O
treatment Reason 4 O O
modality Reason 4 O O
to Reason 4 O O
address Reason 4 O O
a Reason 4 O O
wide Reason 4 O O
variety Reason 4 O O
of Reason 4 O O
unmet Reason 4 O O
medical Reason 4 O O
needs Reason 4 O O
for Reason 4 O O
patients. Reason 4 O O
Advanced Reason 4 O O
programs Reason 4 O O
to Reason 4 O O
show Reason 4 O O
the Reason 4 O O
efficacy Reason 4 O O
into Reason 4 O O
clinical Reason 4 O O
study Reason 4 O O
would Reason 4 O O
be Reason 4 O O
interest Reason 4 O O
of Reason 4 O O
course. Reason 4 O O
However Reason 4 O O
there Reason 4 O O
is Reason 4 O O
limitation Reason 4 O O
to Reason 4 O O
leverage Reason 4 O O
this Reason 4 O O
fast-growing Reason 4 O O
treatment Reason 4 O O
modality Reason 4 O O
by Reason 4 O O
the Reason 4 O O
hurdles Reason 4 O O
like Reason 4 O O
delivery Reason 4 O O
including Reason 4 O O
vector, Reason 4 O O
controlled Reason 4 O O
expression Reason 4 O O
and Reason 4 O O
transgene. Reason 4 O O
Any Reason 4 O O
breakthrough Reason 4 O O
technologies Reason 4 O O
to Reason 4 O O
extend Reason 4 O O
the Reason 4 O O
potential Reason 4 O O
of Reason 4 O O
gene Reason 4 O O
therapy Reason 4 O O
will Reason 4 O O
meet Reason 4 O O
our Reason 4 O O
interest. Reason 4 O O
Areas O O O O
of O O O O
Interest: O O O O
- O O O O
in O O O O
vivo O O O O
gene O O O O
therapy O O O O
- O O O O
AAV O O O O
- O O O O
Oncolytic O O O O
Virus O O O O
- O O O O
As O O O O
therapeutic O O O O
area, O O O O
Sensory O O O O
diseases, O O O O
CNS, O O O O
Muscle O O O O
disorders, O O O O
Cancer O O O O
- O O O O
Genome O O O O
editing O O O O
Close O O O O
